Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2012
07/18/2012CN101579326B Pulullan polysaccharide empty hard capsule and preparation method thereof
07/18/2012CN101537188B Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound
07/18/2012CN101528261B Pharmaceutical compositions of clonazepam and methods of use thereof
07/18/2012CN101524375B Wet-process wall breaking method of lucidum spore powder
07/18/2012CN101442982B Stomach floater composition containing optimization treated starch for inducing satiation sense
07/18/2012CN101439062B Chinese medicine granule containing andrographolide and preparation method thereof
07/18/2012CN101330910B Bisoprolol-containing adhesive patch
07/18/2012CN101321476B Method of improving absorbability of epigallocatechin, food, drink and food/drink material using the same and method of producing the same
07/18/2012CN101234203B Novel medical photosensitive agent for anti-tumor treatment and preparation thereof
07/18/2012CN101137700B Microparticle and pharmaceutical composition
07/18/2012CN101134013B Preparations for oral administration
07/18/2012CN101123936B Oral compositions containing oxidized camellia
07/18/2012CN101108224B Plants natural base extractive and formulated product and use thereof
07/18/2012CN101095654B Cosmetic or medical composition comprising a condensation polymer, the cosmetic processing method of using said composition, said condensation polymer and the method for preparing the same
07/18/2012CN101085019B Traditional Chinese medicinal composition containing red sage root, notoginseng, safflower and musk or muscone and its preparation
07/18/2012CN101085016B Traditional Chinese medicinal composition containing red sage root, notoginseng and ginseng or codonopsis pilosula and its preparation
07/18/2012CN101085004B Traditional Chinese medicinal composition containing red sage root, ligusticum wallichii and borneol or storax and its preparation
07/18/2012CN101039657B Pharmaceutical composition comprising a solid dispersion with a polymer matrix
07/17/2012US8222398 Chimeric immunomodulatory compounds and methods of using the same-II
07/17/2012US8222381 Derivatives of monosaccharides for drug discovery
07/17/2012US8222233 Modifications of solid 3-sn-phosphoglycerides
07/17/2012US8221794 Anti-angiogenic nanoparticle compositions
07/17/2012US8221790 Therapeutic polyesters and polyamides
07/17/2012US8221785 Transdermal hormone delivery system: compositions and methods
07/17/2012US8221784 Transdermal hormone delivery system: compositions and methods
07/17/2012US8221783 Medical devices with triggerable bioadhesive material
07/17/2012US8221779 Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment
07/17/2012US8221765 Multivalent fibronectin based scaffold domain proteins
07/17/2012US8221761 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing CG motifs
07/17/2012CA2706264C Propofol transparent anesthetic solution, with low venous irritation threshold
07/17/2012CA2666492C Stable polypeptide formulations
07/17/2012CA2659917C Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
07/17/2012CA2651445C Solid medicament dosage form consumption aid
07/17/2012CA2620341C Sanitary napkins with hydrophobic lotions
07/17/2012CA2542049C Finely particulate composite containing carbon compound encapsulated therein
07/17/2012CA2523672C Compositions for enhancing transport of molecules into cells
07/17/2012CA2505520C Protein-stabilized liposomal formulations of pharmaceutical agents
07/17/2012CA2502437C Method and composition containing latanoprost for treating ocular hypertension and glaucoma
07/17/2012CA2496699C Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
07/17/2012CA2478480C Coupling low molecular weight compounds to hydroxyalkylstarch via a terminal aldehyde group on the starch
07/17/2012CA2478478C Coupling hydroxyalkyl starch via a terminal aldehyde group or a functional group derived therefrom, to a protein
07/17/2012CA2477217C Topical dapsone for the treatment of acne
07/17/2012CA2436416C Compositions of aminoalkyl methacrylate copolymer e and dissolution modifying excipients for preparing capsules by injection moulding
07/17/2012CA2418984C Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
07/12/2012WO2012094679A2 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors
07/12/2012WO2012094653A2 Compositions and methods for macromolecular drug delivery
07/12/2012WO2012094620A2 Hydrophobic molecule-induced branched polymer aggregates and their use
07/12/2012WO2012094598A2 Pharmaceutical compositions of iron for oral administration
07/12/2012WO2012094574A2 Stabilized polyribonucleotide nanoparticles
07/12/2012WO2012094541A2 Acoustically responsive particles with decreased cavitation threshold
07/12/2012WO2012094512A2 Myocardial tissue targeting peptides
07/12/2012WO2012094511A2 Compositions and methods for the treatment of orthopedic disease or injury
07/12/2012WO2012094360A2 Biotherapeutics for the treatment of infectious diseases
07/12/2012WO2012094033A1 Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
07/12/2012WO2012094020A1 Methods and compositions for delivery of taxanes in stable oil-in-water emulsions
07/12/2012WO2012093524A1 Oil-in-water emulsion composition
07/12/2012WO2012093227A1 Prodrugs for dispensing a statin to the liver
07/12/2012WO2012093171A1 Method for preparing aqueous pharmaceutical suspensions including a drug that is effective in treating rhinitis
07/12/2012WO2012093137A1 Liposome formulation suitable for treating or preventing tuberculosis
07/12/2012WO2012093113A1 O/w-emulsions comprising semifluorinated alkanes
07/12/2012WO2012093068A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide
07/12/2012WO2012092865A1 Cationic polymers formed from amino group-bearing monomers and heterocyclic linkers
07/12/2012WO2012092849A1 Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing loss
07/12/2012WO2012092712A1 Lyophilized nanometer particle powder preparation comprising recombinant albumin prepared from human plasma
07/12/2012WO2012064697A3 Materials presenting notch signaling molecules to control cell behavior
07/12/2012WO2012061360A3 Pharmaceutical compositions
07/12/2012WO2012057492A9 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
07/12/2012WO2012048204A3 Prodrugs utilizing a transporter directed uptake mechanism
07/12/2012WO2012040331A3 Multistage nanoparticles
07/12/2012WO2012021791A3 Aqueous formulation with improved stability
07/12/2012WO2011154724A3 Injectable flowable composition comprising buprenorphine
07/12/2012WO2011128632A3 Gelled pharmaceutical composition
07/12/2012US20120179772 System and method to improve fitness training
07/12/2012US20120178830 Liquid composition to be filled in soft capsules
07/12/2012US20120178828 Process for the preparation of a flavoring concentrate, and a flavoring concentrate
07/12/2012US20120178827 Solid Pharmaceutical Preparations Comprising Amphiphilic Copolymers On The Basis Of Polyethers In Combination With Surfactants
07/12/2012US20120178825 Cyclohexanedimethanol-based hydrophilic polyurethane urea
07/12/2012US20120178824 Hydrogels based on esters of polyisobutenesuccinic acid
07/12/2012US20120178822 Co-Processed Excipient Compositions
07/12/2012US20120178793 Nucleotide-cochleate compositions and methods of use
07/12/2012US20120178728 Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound
07/12/2012US20120178711 Cyclodextrin-based polymers for therapeutics delivery
07/12/2012US20120178692 Dosage forms of polymer-factor viii moiety conjugates
07/12/2012US20120178684 Surgical Calcium Phosphate Citrate-Containing Cement and Method of Manufacturing the Same
07/12/2012US20120178629 Apparatus and methods for preparing an emulsion
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120177737 High drug load tablet
07/12/2012US20120177724 Lipid vesicle compositions and methods of use
07/12/2012US20120177719 Medical device intended to come into contact with a patient's tissue and related manufacturing method
07/12/2012US20120177709 Low ph structured surfactant composition
07/12/2012US20120177703 Solid linear oligo-or poly-e-caprolactone
07/12/2012US20120177702 Solid Forms for Tissue Repair
07/12/2012US20120177698 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
07/12/2012US20120177697 Excipients In Drug Delivery Vehicles
07/12/2012US20120177696 Diffusion-controlled dosage form and method of fabrication including three dimensional printing
07/12/2012US20120177620 Probiotic, Lactic Acid-Producing Bacteria
07/12/2012US20120177592 Degradable thermoresponsive poly(ethylene glycol) analogue materials
07/12/2012US20120177584 Sweetener compositions and methods of making them
07/12/2012US20120177575 Fas (apo-1,cd95) targeted platforms for intracellular drug delivery
07/12/2012CA2834968A1 Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
1 ... 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 ... 1712